Pulmonary inflammation caused by chitosan microparticles

Journal of Biomedical Materials Research - Part A

Volumn 75, Issue 2, 2005, Pages 283-287

  Huang, Y C ^a,b   Vieira, A ^b   Huang, K L ^c   Yeh, M K ^c   Chiang, C H ^a  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^b SIMON FRASER UNIVERSITY   (Canada)

^c TRI SERVICE GENERAL HOSPITAL   (Taiwan)

Author keywords

Chitosan; Inflammation; Microparticles; Neutrophils; Pulmonary

Indexed keywords

BIOLOGICAL ORGANS; CELLS; CYTOLOGY; DRUG PRODUCTS;

CHITOSAN; INFLAMMATION; MICROPARTICLES; NEUTROPHILS; PULMONARY;

PROTEINS;

BIOPOLYMER; CHITOSAN; LACTATE DEHYDROGENASE; MYELOPEROXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOAVAILABILITY; CONTROLLED STUDY; DOSE RESPONSE; DRUG DELIVERY SYSTEM; ENZYME ACTIVITY; EPITHELIUM CELL; GENE DELIVERY SYSTEM; LUNG LAVAGE; MALE; NEUTROPHIL; NONHUMAN; PARTICLE SIZE; PNEUMONIA; RAT;

ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; CHITOSAN; DRUG DELIVERY SYSTEMS; L-LACTATE DEHYDROGENASE; LEUKOCYTES; LIPOPOLYSACCHARIDES; LUNG; MALE; PARTICLE SIZE; PEROXIDASE; PNEUMONIA; RATS; RATS, SPRAGUE-DAWLEY;

EID: 26844439088     PISSN: 00219304     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbm.a.30421     Document Type: Article

References (26)

1. He P, Davis SS, Ilium L. Chitosan microspheres prepared by spray drying. Int J Pharm 1999;187:53-65.
2. Singla AK, Chawla M. Chitosan: some pharmaceutical and biological aspects-an update. J Pharm Pharmacol 2001;53: 1047-1067.
3. van der Lubben IM, Verhoef JC, Borchard G, Junginger HE. Chitosan for mucosal vaccination. Adv Drug Del Rev 2001;52: 139-144.
4. Akbuga J, Ozbas-Turan S, Erdogan N. Plasmid-DNA loaded chitosan microspheres for in vitro IL-2 expression. Eur J Pharm Biopharm 2004;58:501-507.
5. Aksungur P, Sungur A, Unal S, Iskit AB, Squier CA, Senel S. Chitosan delivery systems for the treatment of oral mucositis: in vitro and in vivo studies. J Control Release 2004;98:269-279.
6. Soane RJ, Frier M, Perkins AC, Jones NS, Davis SS, Ilium L. Evaluation of the clearance characteristics of bioadhesive systems in humans. Int J Pharm 1999;178:55-65.
7. Aspden TJ, Illum L, Skaugrud O. The absence of chitosan toxicity when applied to nasal mucosa. Proceed Intern Symp Control Rel Bioact Mater 1995;22:550-556.
8. Sakagami M, Sakon K, Kinoshita W, Makino Y. Enhanced pulmonary absorption following aersol administration of mucoadhesive powder microspheres. J Control Release 2001;77: 117-129.
9. Okamoto H, Nishida S, Todo H, Sakakura Y, Iida K, Danjo K. Pulmonary gene delivery by chitosan-pDNA complex powder prepared by a supercritical carbon dioxide process. J Pharm Sci 2003;92:371-380.
10. Bivas-Benita M, van Meijgaarden KE, Franken KL, Junginger HE, Borchard G, Ottenhoff TH, Geluk A. Pulmonary delivery of chitosan-DNA nanoparticles enhances the immunogenicity of a DNA vaccine encoding HLA-A*0201- restricted T-cell epitopes of Mycobacterium tuberculosis. Vaccine 2004;22:1609-1615.
11. Huang Y, Yeh M, Chiang C. Formulation factors in preparing BTM-chitosan microspheres by spray drying method. Int J Pharm 2002;242:239-242.
12. Huang YC, Yeh MK, Cheng SN, Chiang CH. The characteristics of betamethasone-loaded chitosan microparticles by spray-drying method. J Microencapsul 2003;20:459-472.
13. Ewards DA, Hanes J, Caponetti G., Hrkach J, Ben-Jebria A, Eskew ML, Mintzes J, Deaver D, Lotan N, Langer R. Large porous particles for pulmonary drug delivery. Science 1997; 276:1868-1871.
14. Ben-Jebria A, Chen D, Eskew ML, Vanbever R, Langer R, Edwards D. Large porous particles for sustained protection from carbachol-induced bronchoconstriction in guinea pigs. Pharm Res 1999;16:551-561.
15. Asti C, Ruggieri V, Porzio S, Chiusaroli R, Melillo G., Caselli G.F. Lipopolysaccharide-induced lung injury in mice. I. Concomitant evaluation of inflammatory cells and haemorrhagic lung damage. Pulm Pharmacol Ther 2000;13:61-69.
16. Garcia-Contreras L, Sarubbi D, Flanders E, O'Toole D, Smart J, Newcomer C, Hicke AJ. Immediate and short-term cellular and biochemical responses to pulmonary single-dose studies of insulin and H-MAP. Pharm Res 2001;18:1685-1693.
17. Cochran JR, Khan AM, Elidemir O, Xue H, Cua B, Fullmer J, Larsen GL, Colasurdo GN. Influence of lipopolysaccharide exposure on airway function and allergic responses in developing mice. Pediatr Pulmonol 2002;34:267-277.
18. Scheule RK, St. George JA, Bagley RG, Marshal J, Kaplan JM, Akita GY, Wang KX, Lee ER, Harris DJ, Jiang C, Yew NS, Smith AE, Cheng SH. Basis of pulmonary toxicity associated with cationic lipid-mediated gene transfer to the mammalian lung. Hum Gene Ther 1997;8:689-707.
19. Dokka S, Toledo D, Shi X, Castranova V, Rojanasakul Y. Oxygen radical-mediated pulmonary toxicity induced by some cationic liposome. Pharm Res 2000;17:521-525.
20. Emerson M, Renwick L, Tate S, Rhind S, Milne E, Painter HA, Boyd AC, McLachlan G, Griesenbach U, Cheng SH, Gill DR, Hyde SC, Baker A, Alton EW, Porteous DJ, Collie DD. Transfection efficiency and toxicity following delivery of naked plasmid DNA and cationic lipid-DNA complexes to ovine lung. Mol Ther 2003;8:528-529.
21. Huang M, Khor E, Lim LY. Uptake and cytotoxicity of chitosan molecules and nanoparticles: effects of molecular weight and degree of deacetylation. Pharm Res 2004;21:344-353.
22. Kumar M, Behera AK, Lockey RF, Zhang J, Bhullar G, De La Cruz CP, Chen LC, Leong KW, Huang SK, Mohapatra SS. Intranasal gene transfer by chitosan-DNA nanospheres protects BALB/c mice against acute respiratory syncytial virus infection. Hum Gene Ther 2002;13:415-425.
23. Roy K, Mao HQ, Huang SK, Leong KW. Oral gene delivery with chitosan-DNA nanoparticles generates immunologic protection in a murine model of peanut allergy. Nat Med 1999;5: 387-391.
24. Krauland AH, Guggi D, Bernkop-Schnurch A. Oral insulin delivery: the potential of thiolated chitosan-insulin tablets on non-diabetic rats. J Control Release 2004;95:547-555.
25. Vila A, Sanchez A, Janes K, Behrens I, Kissel T, Jato JLV, Alonso MJ. Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in mice. Eur J Pharm Biopharm. 2004;57:123-131.
26. Agnihotri SA, Aminabhavi TM. Controlled release of clozapine through chitosan microparticles prepared by a novel method. J Control Release 2004;96:245-259.